BGMS stock news
This page provides real-time market news, earnings updates, and company announcements related to Bio Green Med Solution, Inc. (BGMS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-26 13:45 EST
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
Finviz2026-02-20 13:51:55
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-20 21:06:42
Sotera Health Company (SHC) Q4 Earnings Preview: Key Points to Watch
101 finance2026-02-23 03:12:38
Vor Bio to Participate in the 46th Annual TD Cowen Health Care Conference
Finviz2026-02-23 13:03:47
Gossamer Bio Inc. (Ticker: GOSS) recently disclosed the topline data from its Phase III clinical trial, the Prosera study.
老虎证券2026-02-23 13:28:12
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
Finviz2026-02-23 13:42:48
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Finviz2026-02-23 22:15:05
What To Expect From Agilent's (A) Q4 Earnings
Finviz2026-02-24 03:27:47
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-24 13:06:42
What's Going On With Kyntra Bio Stock Tuesday?
Finviz2026-02-24 13:27:44
Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference
Finviz2026-02-24 14:18:43
Qualcomm, Booking Holdings receive upgrades: Leading analyst picks from Wall Street
101 finance2026-02-24 14:45:35
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
Finviz2026-02-24 17:33:10
Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections
Finviz2026-02-24 19:30:43
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
Gossamer Bio (GOSS) Reports Topline Phase 3 Results for Seralutinib in Pulmonary Arterial Hypertension
Finviz2026-02-25 10:54:06
Darling Ingredients (NYSE:DAR) Q4 Results: Outperforming in the Ingredients, Flavors & Fragrances Sector
101 finance2026-02-25 13:03:42
N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
Finviz2026-02-25 13:34:28
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
Finviz2026-02-25 13:48:47
Korro to Present at the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-25 21:09:42
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference
Finviz2026-02-26 13:03:41
FibroBiologics to Present at the BIO Investment & Growth Summit
Finviz2026-02-26 13:33:09
Regenxbio (RGNX) Likely to Surpass Earnings Predictions: Will the Share Price Rise?
101 finance2026-02-26 16:04:08
Gossamer Bio Inc. (Ticker: GOSS) recently disclosed the topline data from its Phase III clinical trial, the Prosera study.
老虎证券2026-02-23 13:28:12
Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026
Finviz2026-02-23 13:42:48
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Finviz2026-02-23 22:15:05
What To Expect From Agilent's (A) Q4 Earnings
Finviz2026-02-24 03:27:47
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-24 13:06:42
What's Going On With Kyntra Bio Stock Tuesday?
Finviz2026-02-24 13:27:44
Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference
Finviz2026-02-24 14:18:43
Qualcomm, Booking Holdings receive upgrades: Leading analyst picks from Wall Street
101 finance2026-02-24 14:45:35
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
Finviz2026-02-24 17:33:10
Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections
Finviz2026-02-24 19:30:43
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-24 21:33:11
Gossamer Bio (GOSS) Reports Topline Phase 3 Results for Seralutinib in Pulmonary Arterial Hypertension
Finviz2026-02-25 10:54:06
Darling Ingredients (NYSE:DAR) Q4 Results: Outperforming in the Ingredients, Flavors & Fragrances Sector
101 finance2026-02-25 13:03:42
N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
Finviz2026-02-25 13:34:28
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
Finviz2026-02-25 13:48:47
Korro to Present at the TD Cowen 46th Annual Health Care Conference
Finviz2026-02-25 21:09:42
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference
Finviz2026-02-26 13:03:41
FibroBiologics to Present at the BIO Investment & Growth Summit
Finviz2026-02-26 13:33:09
Regenxbio (RGNX) Likely to Surpass Earnings Predictions: Will the Share Price Rise?
101 finance2026-02-26 16:04:08
BGMS stock chart
BGMS stock detailsBGMS stock price change
On the last trading day, BGMS stock closed at 0.98 USD, with a price change of -0.03% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more